Replies to post #464552 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

The goal is to get blarcamesine to be FDA approved, then doctors can prescribe blarcamesne as a stand alone drug for many different stand alone indications including Alzheimer’s disease and/ or MCI etc.

Good luck and GOD bless,

[williamssc]

Yes, Dr Sabbagh interestingly makes that remark saying activating the sigma1 receptor triggers Neuroprotection, which may be complimentary to the monoclonal antibody treatment. So taking A-273 for it's Neurprotection while receiving MaB treatments? Both together could get pretty costly.